Summary

Overview
Global Carotid Stenotic Scan Devices Market reached US$ XX billion in 2022 and is expected to reach US$ XX billion by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.
The Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and measure carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. There are 3 types of imaging that can be used to detect carotid artery stenosis. It includes carotid ultrasound, magnetic resonance angiography, or computed tomographic angiography. Carotid stenosis (CS) is the narrowing or blockage of the carotid arteries caused by plaque buildup, which may increase the risk of cerebrovascular events.
Among all regions, the North America is expected to hold the largest share of the global market over the forecast period. The increase in the number of neurological disorders will hold the dominant share of the market. Doppler ultrasound segment holds a significant position in the market share.
Dynamics
Increase in the Prevalence of Coronary Artery Diseases will Elevate the Market Growth
Coronary artery disease causes the narrowing of arteries. This narrowing is usually caused by the buildup of fatty substances and cholesterol deposits called plaque. The diagnosis of coronary artery disease is based on typical imaging criteria, either by cardiac CT or invasive coronary angiography. An increased number of coronary artery diseases is expected to increase market growth.
For instance, according to the CDC, coronary artery disease (CAD) accounts for approximately 610,000 deaths annually (estimated 1 in 4 deaths) and is the leading cause of mortality in the United States. It is the third leading cause of mortality worldwide and is associated with 17.8 million deaths annually. Thus, an increase in the number of coronary artery diseases will elevate the market growth.
High Costs Associated with the Devices can Decline the Market Growth
High costs associated with the devices and procedures can cause a decline in market growth. It will limit the affordability and accessibility of the devices and can limit their adoption and usage. This, in turn, could potentially slow down the market’s growth. The results that have to be interpreted require additional technology.
The cost of these devices is expected to be higher because of the advanced technology used, and the complexity of operating the equipment would additionally increase the market’s growth. The skilled technicians will contribute to the high cost of the equipment. Lowering the cost of these devices and alternative options for the canning devices can overcome the challenges of the market.
Segment Analysis
The global carotid stenotic scan devices market is segmented based on product, end-user and region.
Doppler Ultrasound Segment is Expected to Hold the Largest Market Share in the Global Carotis Stenotic Scan Devices Market
The advantages of doppler ultrasound over the other products are expected to hold the segment in the dominant market share. Besides estimating the degree of stenosis, sonography is able to characterize plaques and identify those with a higher stroke risk. Color Doppler imaging is a reliable method for evaluating vertebral artery stenosis.
The variants of the doppler ultrasound, such as color and grayscale imaging ultrasound imaging, will dominate the advantages. Grayscale ultrasound imaging, combined with color doppler and spectral waveform analysis, is a widely available tool that can assess the morphology of plaques and detect hemodynamically significant stenosis. Thus, the above factors are expected to hold the segment in the dominant share.
Geographical Penetration
North America Region Holds the Largest Market Share in the Global Carotid Stenotic Scan Devices Disease Market
North America is expected to hold a dominant share of the market share. The increase in the number of brain injuries is expected to drive the market growth in this region. For instance, according to the Brain Injury Association of America, there are more than 5.3 million individuals in the United States who are living with a permanent brain injury-related disability. That’s one in every 60 people. At least 2.8 million Americans annually sustain traumatic brain injuries in the United States.
Additionally, in North America, about 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. A carotid ultrasound is done with carotid stenotic scan devices to look for narrowed carotid arteries, which increase the risk of stroke. Thus, the increase in the prevalence of brain strokes is expected to raise the demand for the devices. Thus, the above factors are expected to hold the region in the dominant position.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global carotid stenotic scan devices market. As countries grappled with lockdowns, the diagnostic and treatment procedures were impacted negatively by impacting the whole market.
The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting the appointments and resulting in the postponements of the diagnosis. The hospitals and the diagnostic centers were closed, increasing the prognosis of the disease. The new developments and launches have been halted due to COVID-19. Thus, it has negatively impacted the global carotid stenotic scan market.
By Product
• Doppler Ultrasound
• CT Angiogram (CTA)
• Magnetic Resonance Angiography (MRA)
By End-User
• Hospital
• Ambulatory Surgery Centers (ASCS)
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The global carotid stenotic scan devices market is fragmented, with the presence of many local and international players. Tekna, Inc., Stanford Health Care., Canon Medical Systems Corporation, Rimed Ltd, Koninklijke Philips N.V., FUJIFILM Asia Pacific Pte. Ltd., BPL Medical Technologies, Siemens Healthcare Private Limited, Cedars Sinai, Lepu Medical Technology (Beijing)Co., Ltd. are the leading companies with a significant market share.
Why Purchase the Report?
• To visualize the global carotid stenotic scan devices market segmentation based on product, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of carotid stenotic scan devices at the market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global carotid stenotic scan devices market report would provide approximately 61 tables, 58 figures, and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by End-User
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increase in the prevalence of coronary artery diseases
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High costs associated with the devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Doppler Ultrasound *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Magnetic Resonance Angiography (MRA)
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospital *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgery Centers (ASCS)
8.4. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. UK
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. South Korea
9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Tekna, Inc. *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Stanford Health Care.
11.3. Canon Medical Systems Corporation
11.4. Rimed Ltd
11.5. Koninklijke Philips N.V.
11.6. FUJIFILM Asia Pacific Pte. Ltd.
11.7. BPL Medical Technologies
11.8. Siemens Healthcare Private Limited
11.9. Cedars Sinai.
11.10. Lepu Medical Technology (Beijing)Co., Ltd.
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us